Johnson Fistel Commences Investigation of Agilon Health, Inc.

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Agilon Health, Inc. regarding possible violations of federal securities laws following significant leadership changes and financial disclosures that negatively impacted the company's stock price [1][3]. Company Developments - On August 4, 2025, Agilon Health, Inc. announced the resignation of its President, CEO, and Board Director, Steven Sell, from all positions [3]. - The company released its second-quarter 2025 financial results and withdrew its previously issued full-year 2025 earnings guidance, which surprised the market [3]. - Following these announcements, Agilon's share price fell by more than 27% in after-hours trading [3]. Legal Investigation - The investigation by Johnson Fistel focuses on whether Agilon failed to disclose material information to investors regarding the timing, circumstances, or implications of its leadership transition and guidance withdrawal, potentially violating federal securities laws [3].